SK Hynix shares jumped as much as 11.6% on Thursday after the South Korean chipmaker unveiled plans for a massive Nasdaq listing of American depositary receipts (ADRs), aiming to raise up to 45.45 trillion won ($29.4 billion). The offering, which involves up to 17.79 million new shares, is expected to begin trading on the Nasdaq Global Select Market on July 10. If completed at the upper end, it would surpass Saudi Aramco's 2019 IPO and Alibaba's 2014 listing, trailing only SpaceX's recent record deal.

The move is not just about capital—it signals a strategic bid to reposition SK Hynix in the eyes of US investors. Currently valued largely as a memory-cycle name tied to the Korean market, the company hopes a Nasdaq listing will align it with AI infrastructure peers like Micron and Nvidia. Analysts argue that trading alongside these names could trigger a valuation rerating, as high-bandwidth memory (HBM) is increasingly viewed as a scarce AI input rather than a commodity chip.

Read also
Stocks
Q32 Bio Stock Soars 81%: Why Taking Profits Now May Be Prudent
Q32 Bio's stock doubled after promising alopecia trial results, but small sample sizes, dilution risk, and a distant commercialization timeline warrant profit-taking.

Why Nasdaq Over NYSE?

The choice of Nasdaq is deliberate. Ryu Young-ho, senior analyst at NH Investment & Securities, told Reuters that the key benefit is SK Hynix will trade alongside Micron, giving it a chance to be "re-rated in the US market." Kim Sun-woo of Meritz Securities echoed this, noting that ADR issuance could attract funds already holding Micron and spark a sharp revaluation, as reported by Maeil Business Newspaper.

There is also a passive-flow angle. If SK Hynix eventually enters US semiconductor or tech benchmarks, index-linked funds and ETFs would be compelled to buy shares, providing built-in demand beyond active stock pickers. This could further support the rerating narrative, though it is not guaranteed.

Capacity Bet Behind the Capital Raise

The $29.4 billion raise is a capacity bet. SK Hynix is already a dominant player in HBM, which is a critical bottleneck in the AI supply chain. Counterpoint Research director MS Hwang told CNBC that SK Hynix is the "top-notch player" in HBM, with the "best product, lowest cost." Proceeds from the ADR sale are expected to fund the Yongin Y1 fab (31 trillion won) and a Cheongju advanced packaging plant (19 trillion won), according to Tom's Hardware.

This expansion aligns with surging demand from Nvidia, Google, and other AI giants that require massive volumes of advanced memory for their accelerators. However, the cyclical nature of memory chips remains a risk. If hyperscalers slow data-center spending or delay orders, SK Hynix could feel the impact quickly.

Market Context and Risks

The rerating argument is powerful but not risk-free. Memory chips are inherently cyclical, and while AI demand has reshaped the cycle, it has not abolished it. Pricing weakness or a cooling in AI/HBM demand could reverse the rerating. Additionally, market concentration risk looms: Samsung Electronics and SK Hynix together account for over 55% of the KOSPI's market capitalization.

For investors, the Nasdaq listing opens a new chapter. The stock's jump reflects optimism that Wall Street will finally value SK Hynix as an AI infrastructure leader. Yet, the memory-cycle label may persist if fundamentals falter. As the July 10 trading date approaches, the market will watch closely whether this listing indeed triggers a lasting rerating or proves to be a short-term catalyst.

This article is for informational purposes only and does not constitute financial advice.